Physician

Christopher Terrence Haley, M.D.

According to 2025 Medicare claims, Christopher Haley, M.D. (NPI: 1013368851) practices dermatology in the Killeen-Temple, TX market, with the plurality of this provider's patient population coming from Bell, TX. This provider's primary affiliated billing organization is SCOTT & WHITE CLINIC (NPI: 1093779704; TIN: 742958277) and primary practice location at 76508-0001. Haley is affiliated with the Baylor Scott & White Quality Alliance (ACO ID: A2542), participating under the MSSP model.

Haley's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 535 traditional Medicare patients, billed 2,811 HCPCS/CPT codes, and received $137,980 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,274 prescription claims across 442 beneficiaries totaling $600,164 in drug costs, led by Skyrizi Pen (Risankizumab-Rzaa). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $8,244 to $600,164. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$69K$138K2022 Medicare payment: $42,422 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $104,721 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $137,980 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022174735$42,422
20234102,237$104,721
20245352,811$137,980

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$300K$600K2019 Drug cost: $8,244 (USD; Tot_Drug_Cst)2020 Drug cost: $83,758 (USD; Tot_Drug_Cst)2021 Drug cost: $51,564 (USD; Tot_Drug_Cst)2022 Drug cost: $60,208 (USD; Tot_Drug_Cst)2023 Drug cost: $297,772 (USD; Tot_Drug_Cst)2024 Drug cost: $600,164 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
201998178$8,244
2020204521$83,758
2021141431$51,564
2022203448$60,208
20233961,042$297,772
20244421,274$600,164

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more177224$63
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more222257$43
17000Destruction of precancer skin growth, 1 growth217263$34
11102Biopsy of related skin growth, first growth108128$18
17003Destruction of precancer skin growth, 2-14 growths1801,097$1

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Skyrizi PenRisankizumab-Rzaa11924$243,573
Dupixent PenDupilumab37994$135,277
Clobetasol PropionateClobetasol Propionate1033,267$4,203
FluorouracilFluorouracil541,725$3,248
FluocinonideFluocinonide642,145$2,501

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Christopher Terrence Haley, M.D.?

Tedicare shows public-source Medicare data for Christopher Terrence Haley, M.D. (NPI 1013368851), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Christopher Terrence Haley, M.D. have ACO affiliation data?

Christopher Terrence Haley, M.D. is shown with ACO affiliation data for Baylor Scott & White Quality Alliance (MSSP, ACO ID A2542).

What billing organization is linked to Christopher Terrence Haley, M.D.?

Christopher Terrence Haley, M.D. is linked to SCOTT & WHITE CLINIC (billing NPI 1093779704) in the available physician profile data.

Does Christopher Terrence Haley, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.